Stay updated with breaking news from Ptpi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI – Get Free Report) was the target of a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 57,700 shares, a decline of 21.9% from the July 31st total of 73,900 shares. Based on an average daily trading volume, of 360,000 […] ....
By Josh Beckerman Petros Pharmaceuticals shares declined 9% to $3.24 Friday after the company announced a $15 million private placement. Petros, which. ....
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI – Get Rating) was the target of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 34,100 shares, a decline of 22.5% from the March 31st total of 44,000 shares. Based on an average daily trading volume, of 2,450,000 shares, […] ....
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI – Get Rating) was the target of a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 34,100 shares, a decline of 22.5% from the March 31st total of 44,000 shares. Based on an average daily volume of 2,450,000 shares, the […] ....
On Friday, Petros Pharmaceuticals (NASDAQ: PTPI) stock witnessed a significant uptick in value, despite the absence of any company updates regarding its men's health pharmaceutical products. There’s no evidence of any press release or filed reports with the U.S. Securities or Exchange Commission to explain the rise in value. To Find out the inside Scoop ....